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Structural Basis of CTP-Dependent Peptide Bond
Formation in Coenzyme A Biosynthesis Catalyzed
by Escherichia coli PPC Synthetase
ate and then, (R )-4-phospho-N-pantothenoylcysteine
(PPC) is synthesized by the addition of cysteine to
4-phosphopantothenate. In the next step, PPC is decar-
boxylated to 4-phosphopantetheine, which is subse-
quently converted to coenzyme A by adenylylation and
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Despite the essential role of 4-phosphopantetheineD-82152 Martinsried
Germany and coenzyme A in metabolism, only recently have
genes involved in the biosynthesis of these cofactors in2 Lehrstuhl fu¨r Mikrobielle Genetik
Universita¨t Tu¨bingen bacteria, Arabidopsis thaliana, and human been cloned
and characterized (Daugherty et al., 2002; Geerlof et al.,Auf der Morgenstelle 15, Verfu¨gungsgeba¨ude
D-72076 Tu¨bingen 1999; Kupke, 2002; Kupke et al., 2000, 2003; Mishra et
al., 2001; Song and Jackowski, 1992; Strauss et al.,Germany
2001). As a result of these studies, the key reaction of
coenzyme A biosynthesis, the formation of 4-phospho-
pantetheine from 4-phosphopantothenate, is now wellSummary
understood. The enzymatic synthesis of the peptide
bond present in 4-phosphopantetheine is a nucleoside-Phosphopantothenoylcysteine (PPC) synthetase forms
triphosphate-dependent reaction (Brown, 1959)—thusa peptide bond between 4-phosphopantothenate and
the 4-phosphopantetheine cofactor is not involved incysteine in coenzyme A biosynthesis. PPC synthe-
its own biosynthesis. In most eubacteria, 4-phospho-tases fall into two classes: eukaryotic, ATP-dependent
pantetheine is synthesized from 4-phosphopantothen-and eubacterial, CTP-dependent enzymes. We de-
ate and cysteine by the bifunctional Dfp (CoaBC) flavo-scribe the first crystal structure of E. coli PPC synthe-
protein in a multistep procedure (Herna´ndez-Acosta ettase as a prototype of bacterial, CTP-dependent PPC
al., 2002; Kupke, 2000, 2001, 2004; Kupke et al., 2000;synthetases. Structures of the apo-form and the syn-
Strauss and Begley, 2001; Strauss et al., 2001) (Figure 1).thetase complexed with CTP, the activated acyl-inter-
The COOH-terminal CoaB domain of Dfp is the 4-phos-mediate, 4-phosphopantothenoyl-CMP, and with the
phopantothenoylcysteine synthetase (systematic name:reaction product CMP provide snapshots along the
(R )-4-phosphopantothenate:L-cysteine ligase; EC 6.3.2.5)reaction pathway and detailed insight into substrate
which activates 4-phosphopantothenate by reaction withbinding and the reaction mechanism of peptide bond
CTP. The 4-phosphopantothenoyl-cytidylate formed isformation. Binding of the phosphopantothenate moi-
attacked by cysteine and PPC is synthesized. Theety of the acyl-intermediate in a cleft at the C-terminal
FMN-dependent decarboxylation of PPC to 4-phos-end of the central  sheet of the dinucleotide binding
phopantetheine is catalyzed by the NH2-terminal CoaCfold is accomplished by an otherwise flexible flap. A
domain. FMN-dependent decarboxylation was firstsecond disordered loop may control access of cysteine
shown for the EpiD enzyme that catalyzes the oxidativeto the active site. The conservation of functionalities
decarboxylation of peptidylcysteines (Kupke et al., 1994,involved in substrate binding and catalysis provides
1995), a reaction involved in the biosynthesis of someinsight into similarities and differences of prokaryotic
lantibiotics (Schnell et al., 1988). Due to the enzymaticand eukaryotic PPC synthetases.
activity of the NH2-terminal flavin-binding CoaC domain,
Dfp was classified as HFCD flavoprotein (homo-oligo-Introduction
meric flavin-containing Cys decarboxylases) (Blaesse et
al., 2000; Kupke et al., 2000).4-Phosphopantetheine and coenzyme A are essential
The PPC-synthetase domain of Dfp was biochemicallycofactors in the metabolism of fatty acids, the biosyn-
studied and characterized by site-directed mutagenesisthesis of polyketides and nonribosomal peptides, and
(Kupke, 2002, 2004). Exchange of the residue Asn210many other reactions (Abiko, 1975; Kleinkauf, 2000). Co-
led to partial or complete block of the second half reac-enzyme A was discovered and characterized by Fritz
tion and enabled the copurification of a reaction interme-Lipmann (Lipmann, 1964), and Feodor Lynen (Lynen,
diate that was then identified as 4-phosphopantothen-1973) elucidated that the thiol group of coenzyme A is
oyl-CMP by MALDI-TOF-MS. It was concluded thatthe functional group by activating substrates as thioes-
mutation of Asn210 to Asp either impairs cysteine bind-ters (Lynen, 1973). Coenzyme A is synthesized in five
ing or influences the nucleophilic attack on the 4-phos-enzymatic steps from pantothenate (Brown, 1959). Pan-
phopantothenoyl-CMP intermediate by cysteine. E. colitothenate is phosphorylated to 4-phosphopantothen-
CoaB is not absolutely specific for L-cysteine and can
also couple thiol compounds such as cysteamine with
*Correspondence: thomas.kupke@t-online.de (T.K.); steinbac@ 4-phosphopantothenate (Kupke, 2004), a result which
caltech.edu (S.S.)
is in accordance with substrate specificity experiments3Present address: Division of Chemistry and Chemical Engineering,
carried out by G. Brown with crude PPC-synthetaseMail Code 114-96, California Institute of Technology, Pasadena,
California 91125. preparations from Proteus morganii (Brown, 1959). In
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Figure 1. Reactions Performed by E. coli Dfp
Protein
CoaB forms 4-phosphopatothenoyl-cysteine
(PPC) that is decarboxylated by the flavopro-
tein CoaC. CTP is utilized to activate 4-phos-
phopantothenic acid by forming a covalent
intermediate, 4-phosphophopantothenoyl-
CMP. The peptide bond formed by CoaB is
highlighted in the product.
summary, Dfp is an enzyme catalyzing the synthesis throughout this study as it shows a higher expression
level compared to the wild-type. In addition, its bio-of phosphopeptide-like structures using the cofactors
Mg2, CTP, and FMN. chemical characterization demonstrated a very low ac-
tivity for lysis of the acyl-intermediate by cysteineFrom genetic footprinting experiments, it was con-
cluded that in E. coli, all five biosynthetic genes involved (Kupke, 2002, 2004).
The structure of ligand-free ecCoaB was solved byin coenzyme A biosynthesis are essential (Gerdes et al.,
2002). In contrast to bacterial enzymes, the human PPC multiple anomalous dispersion at 2.7 A˚ with data col-
lected from a SeMet derivative and subsequently refinedsynthetase uses ATP for the coupling reaction more
efficiently than CTP (Daugherty et al., 2002). Because at 2.4 A˚ using native data to R  22.1% (Rfree  27.9%)
(Tables 1 and 2, Figure 2). The crystals belong to spaceof this difference between bacterial and human PPC
synthetase, the bacterial PPC synthetase has been dis- group C2 with one monomer in the asymmetric unit. The
final model of the ligand-free ecCoaB structure startscussed as a potential drug target (Daugherty et al., 2002;
Gerdes et al., 2002; Manoj et al., 2003; Strauss et al., at Pro182 and ends with Arg405. No electron density is
present for residues Ser181, Thr284 to Glu299, and the2001). On the other hand, it was reported that E. coli
can reincorporate exogenous pantetheine (but not exo- C-terminal Arg406. The crystallographic 2-fold axis gen-
erates dimers in the crystals that are identical to thosegenous 4-phosphopantetheine) into the coenzyme A
biosynthetic pathway (Jackowski and Rock, 1984), indi- found in the orthorhombic crystal form of ecCoaB de-
scribed below and human CoaB (Manoj et al., 2003).cating that E. coli can grow in media containing pante-
theine even if the PPC synthetase activity is inhibited. The secondary structure assignment and sequence
alignment to the human enzyme are given in Figure 3.The utilization of exogenous pantetheine requires its
uptake and subsequent phosphorylation to 4-phospho- The dimer has the form of an arch with two globular
subunits as side walls and a dimerization domain aspantetheine.
Recently, the structure of the human PPC synthetase gable. The overall dimensions are about 35  35  85 A˚
with an inner width of the arch of about 12 A˚. The Nin its ligand-free form was determined at 2.3 A˚ resolution
and the ATP and 4-phosphopantothenate binding sites termini that are covalently attached to the PPC decar-
boxylase (CoaC) core in intact Dfp are placed aboutwere deduced from modeling studies (Manoj et al.,
2003). In order to enable the structure-based develop- 60 A˚ apart.
Cocrystallization of the enzyme with CTP yielded ament of bacterial PPC synthetase inhibitors and to gain
more insight into the mechanism of peptide bond forma- new crystal form of orthorhombic space group C222(1)
with three monomers in the asymmetric unit that formtion catalyzed by PPC synthetases, the structure of
E. coli CoaB was determined. Here, we report the crystal the same dimers as the ligand-free form. Monomers A
and B in the asymmetric unit form a dimer. A 2-foldstructures of CoaB Asn210Asp, of CoaB Asn210Asp in
complex with CTP and Ca2 ions, and of CoaB N210D crystallographic axis generates a dimer from monomer
C. The same crystal form, however markedly nonisomor-in complex with the activated acyl-intermediate 4-phos-
phopantothenoyl-CMP. The experimentally determined phous, was yielded when ecCoaB was cocrystallized
with CTP and 4-phosphopantothenate. In the lattercofactor and substrate binding sites differ significantly
from those of the human enzyme, a result which is dis- case, the activated intermediate 4-phosphopantothen-
oyl-CMP was formed in situ and remained tightly boundcussed in detail. Based on the E. coli CoaB structures,
a mechanism for the formation of 4-phosphopantothen- to the enzyme as observed for the mutation Asn210Asp
(Kupke, 2004). This mutant, however, seems to haveoyl-CMP is suggested.
enough residual activity to allow lysis of the intermediate
by cysteine, as soaking of cocrystals containing theResults and Discussion
acyl-cytidylate intermediate with varying concentrations
of cysteine or cysteamine for different times alwaysStructure Determination
The bifunctional E. coli protein Dfp harbors the activity of showed CMP as reaction product in the electron density
and a phosphate ion at the binding site of the 4-phos-PPC synthetase (CoaB) and PPC decarboxylase (CoaC),
which perform two consecutive steps in coenzyme A phopantothenate. The quality of these densities was
better for shorter soaking times of about 15 min, whichbiosynthesis. In the present study we determined the
structure of the C-terminal recombinant fragment of indicates a slow diffusion of reaction products from the
binding sites in the crystals.E. coli Dfp protein spanning Ser181 to Arg406 which
harbors the PPC synthetase activity. We will refer to this The orthorhombic crystal forms were solved by mo-
lecular replacement using the ligand-free structure as afragment as ecCoaB. The mutant Asn210Asp was used
Structure of Bacterial CoaB
1979
Table 1. Summary of Data Collection and Processing Statistics
Se (Peak) APO CTP PCMP CMP
Wavelength (A˚) 0.9797 0.950 0.9789 0.9789 1.050
Resolution (A˚) 20–2.5 20–2.4 20–2.5 20–2.3 20–2.85
Last shell (A˚) 2.50–2.54 2.4–2.5 2.5–2.6 2.30–2.38 2.85–2.92
Space group C2 C2 C222(1) C222(1) C222(1)
Cell dimensions (A˚) a  52.3 a  52.9 a  45.9 a  43.6 a  45.8
b  57.3 b  57.3 b  144.4 b  142.6 b  144.3
c  77.2 c  78.8 c  246.2 c  244.6 C  245.1
  109.1   108.9
Monomers in 1 1 3 3 3
asymmetric unit
Unique reflections 7,946 8,804 28,789 32,347 19,252
Multiplicity 5.8 7.5 3.1 2.9 3.0
Completeness (%) 95.6 (86.0) anomalous 99.9 (100.0) 99.5 (99.8) 93.4 (97.1) 98.7 (92.9)
Rmerge (%) 6.0 (52.2) 5.4 (49.6) 6.5 (42.7) 8.8 (29.7) 4.2 (20.2)
I/(I) 19.8 (3.0) 18.7 (3.7) 18.0 (3.4) 15.1 (3.1) 38.7 (5.5)
Values for the outer resolution shell are given in parentheses.
search model. The CTP cocrystallized ecCoaB structure calcium from the crystallization buffer, is coordinated
by - and -phosphates of CTP, two water molecules,was refined to R  21.1% (Rfree  25.8%) at a resolution
of 2.5 A˚. The 4-phosphopantothenoyl-CMP was refined and Asp279, which is strictly conserved throughout bac-
terial and eukaryotic CoaB proteins (Asp183 in humanto R  19.6% (Rfree  26.6%) at a resolution of 2.3 A˚
(Tables 1 and 2). CoaB). Ligand distances at the divalent metal have been
loosely constrained to 2.1 A˚ during refinement. An oxy-
gen atom of the -phosphate of CTP is located furtherBinding of CTP
Cocrystallization of ecCoaB with CTP showed clear den- away at about 3 A˚ from the divalent metal. It cannot
be excluded that this distance would be different forsity for CTP in a well defined pocket at the N terminus
of helix 4 (Figure 4A). A divalent metal ion, presumably magnesium ions which will likely represent the active
Table 2. Summary of Refinement Statistics
APO CTP PCMP CMP
Resolution range (A˚) 20–2.4 20–2.5 20–2.3 20–2.85
Protein atoms 1529 4705 5040 5027
Water atoms 77 159 258 106
Ligand atoms — 87 117 63
Phosphate atoms — — — 15
Ca ions — 3 — —
Number of reflections 8106 (92.0%) 27,197 (94%) 30,744 (88.8%) 18,316 (93.9%)
in working set
Number of reflections 698 (7.9%) 1,592 (5.5%) 1,603 (4.6) 936 (4.8%)
in test set
Rcrysta (%) 22.1 21.1 19.6 21.2
Rfreeb (%) 27.9 25.8 26.6 27.5
Rms deviation from 0.012
ideal geometry
Bonds (A˚) 0.012 0.011 0.011 0.012
Angles (	) 1.73 1.62 1.67 1.78
Average B factors (A˚2)
Protein 66.0 73.3 39.9 64.3
Ligand — 66.4 31.5 77.5
Water 69.3 75.6 44.0 58.7
Calcium — 76.6 — —
Phosphate — — — 77.7
Ramachandran plot 86.4/13.6 86.5/12.7 92.3/7.5 84.7/13.9
(in most favorable/
additional allowed
regions in %)
PDB entry 1U7U 1U7W 1U7Z 1U80
a Rcryst  
hklW
||Fobs|
 k|Fcalc||/
hklW
|Fobs|
b Rfree  
hklT
||Fobs|
 k|Fcalc||/
hklT
|Fobs|
APO, ligand-free structure; CTP, cocrystallized with CTP; PCMP, cocrystallized with 4-phosphopantothenate and CTP which results in bound
4-phosphopantothenoyl-cytidylate; CMP, a PCMP crystal soaked with cysteine.
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Figure 2. Dimer of ecCoaB
(A) Side view.
(B) Top view. The enzyme is composed of globular domains with Rossmann-fold. A dimerization domain that formed from insertions into the
compact domains mediates dimer formation.
(C) Topology diagram of ecCoaB.
metal in vivo. A noticeable network of balanced positive carbonyl oxygens of Gly273 and Ala275 (which is ex-
changed for Thr in the Dfp protein from the temperature-and negative charges participates in CTP binding. These
involve Lys289, Lys341, Lys345, and Arg344, which con- sensitive E. coli dfp-1 mutant [Kupke, 2004]) to the 2-
and 3-hydroxyl groups of ribose, respectively. Thetact CTP phosphates, and Asp309 and Glu330, which
are found in proximity to the positively charged residues 5-methylene group is in van der Waals contact to the
carbonyl oxygen of Phe327. The side chain of Val311(Figure 4A).
Lys289 represents the first lysine of the Lys289-X-Lys- supports part of the ribose ring by a hydrophobic inter-
action with C1 and O4.Lys-motif (X  Ile in ecCoaB) that is conserved in all
CoaB proteins from eubacteria, eukaryotes, and archaea. Overall, CTP binding positions the - and -phos-
phates away from a pronounced cleft across the mole-This motif is located in the dimerization domain and part
of a loop that reaches out to the neighboring subunit. cule which serves as binding site for the 4-phosphopan-
tothenoyl-moiety (see below). In this geometry, theIt has previously been suggested to bind the phosphate
group of CTP or 4-phosphopantothentate (Kupke, -phosphate is ideally positioned for the nucleophilic
attack of the carboxylate group of 4-phosphopanto-2002). We find that Lys289 is ordered only in monomer
B and contacts the P oxygen atoms of CTP of the thenate to form 4-phosphopantothenoyl-CMP with di-
phosphate as leaving group.adjacent monomer. Ile290 is partially ordered in some
subunits but Lys291 and Lys292 are disordered in all
crystal forms. Binding of 4-Phosphopantothenoyl-CMP
The binding site of the activated intermediate 4-phos-The ribose of CTP interacts mainly with the protein
backbone. Hydrogen bonds are formed between the phopantothenoyl-CMP is located in the loop structures
Structure of Bacterial CoaB
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Figure 3. Alignment of CoaB Proteins
For E. coli (Eco) and human (Hsa), the alignment is structure based. The secondary structure of ecCoaB is depicted above, for human CoaB,
below the alignment. Strictly conserved residues in yellow, conservatively replaced in blue. The substrate binding flap and residues involved
in substrate binding in ecCoaB are colored in red. The disordered loop (Lys291/Lys292 to Glu299), which probably controls access to the
active site of a neighboring subunit, is shaded gray. Sequences are given for CoaB proteins from E. coli, Haemophilus influenzae, Bacillus
subtilis, Saccharomyces cerevisiae, mouse, and man. The asterisk indicates the insertion in human CoaB forming the second dimerization
domain.
connecting the C-terminal ends of the central parallel  Reaction of the Acyl-Cytidylate with Cysteine
A generally accepted mechanism for the lysis of thesheet (Figure 4B). Referring to the Rossmann-fold topol-
ogy, the phosphate of 4-phosphopantothenate binds acyl-phosphate intermediate involves the nucleophilic
attack on the carbonyl carbon to form a tetrahedralat the N terminus of the helix of the first -module
(Figure 4C). The pantothenate chain extends through a transition state. The reaction is similar to that catalyzed
by proteases. The ideal position of the amino-group ofgap between  strands 4 and 5. The cytidyl-moiety is
anchored at the N terminus of the  helix of the fourth cysteine for this attack would be above the carbonyl
carbon perpendicular to the plane formed by the car--module which is located at the opposite site of the
4-phosphopantothenoyl-phosphate binding site. The bonyl-group and the CMP-oxygen linked to it. There
are no structural data concerning the binding mode of4-phosphopantothenoyl-moiety is covered by an other-
wise flexible substrate binding clamp (Asp354 to Ala368) cysteine to the acyl-intermediate complex. However, the
postulated mechanism imposes severe restrictions onthat is reminiscent of a partially unwound  helix. Topo-
logically, a part of this flap corresponds to the  helix the latter. Interestingly, a water molecule (W1) is found
in all three molecules comprising the asymmetric unitof -module 6. The substrate binding flap contributes
Val355 and Phe362 to a hydrophobic core that includes of the crystals at about 3 A˚ distance from the carbonyl
carbon atom (Figures 5A and 5B). This position maythe pantothenate methyl groups. The backbone amide
of Asn363 is located at the phosphate binding site that roughly indicate the expected location of the amino-
group of cysteine.is mainly formed by the side chains and backbone am-
ides of Ser212 and Ser213, as well as the backbone As serine is not recognized as a substrate by the
enzyme, the thiol group is expected to form very specificamides of Lys215 and Met216.
Structure
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Figure 4. Substrate Binding
Simulated annealing omit electron densities for bound ligands were calculated from final models.
(A) CTP, a divalent metal ion (Ca2 in yellow) and Lys289 which contacts the -phosphate of CTP.
(B) 4-phosphophopantothenoyl-CMP and a water molecule (red) at the scissile acyl-phosphate bond. The water molecule probably marks
the binding site of cysteine (compare Figure 5).
(C) The reaction product CMP observed after soaking the intermediate complex (Figure 4B) with cysteine. The phosphate-moiety observed
in the product complex probably originates from the otherwise disordered reaction product PPC.
contacts. In addition, the thiol binding site appears to which is 5 A˚ away from the W1. The side chain of Val205
(human CoaB: Val54) is found in different conformationshave a well defined size, as D,L-homocysteine do not
serve as substrates either (Kupke, 2004). A small, largely in the three monomers of the asymmetric unit. De-
pending on the side chain conformation of Val205, thishydrophobic cavity is formed by parts of the intermedi-
ate, Val205, Ala276, Ala329, Val355, and Phe362 (from cavity can be large enough to accommodate the thiol
side chain of cysteine. The hydrophobicity of this poten-the flexible flap). A polar group pointing into the cavity is
the backbone carbonyl of His211 (human CaoB: Phe60) tial thiol binding cavity may explain why the more polar
Structure of Bacterial CoaB
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Figure 5. Active Site Architecture
(A) Accessible surface of the ecCoaB active site for the bound intermediate 4-phosphopantothenoyl-CMP (Figure 4B). At the entrance to the
active site, the disordered residues Il290 and Glu299 may control substrate entrance.
(B) Active site with bound 4-phosphopantothenoyl-CMP. Asp210 is Asn in the wild-type enzyme.
hydroxyl-group of serine is not bound and its small size of a salt bridge, or destabilize a developing negative
charge on the carbonyl-oxygen of the intermediate in awhy larger side chains are not accepted.
CoaB is not absolutely specific for L-cysteine but cou- tetrahedral transition state. The mutant Asn210Asp had
shown very low enzymatic activity in vitro. However,ples also thiol compounds like cysteamine and cysteine
methyl ester to 4-phosphopantothenate (Kupke, 2004). residual activity must be present as soaking of 4-phos-
phopantothenoyl-CMP bound crystals with cysteine atThis indicates that the carboxylate group of cysteine
is involved in much less stringent contacts. Modeling two to 10 mM concentration for 15 min to two hours
yielded only density for CMP and a phosphate ion ofcysteine in such a way that its amino group is located
above the carbonyl carbon of the acyl intermediate (near varying quality. This experiment nevertheless demon-
strates that the 4-phosphopantothenoyl-CMP com-W1) and the thiol-group bound to the above mentioned
cavity would orient its carboxylate group toward the plexed protein is present in an enzymatically active con-
formation in the crystals.solvent. Such a binding mode would be compatible with
the observed substrate specificity.
Asp210, which is Asn in the wild-type enzyme (human: Mechanistic Similarity to Pantothenate Synthetases
Two peptide bonds are introduced into coenzyme AAsn59), contacts W1 and a second water molecule W2
that bridges the CMP phosphate moiety and the cabonyl catalyzed by the pantothenate- and the 4-phospho-
pantothenoylcysteine synthetases. As the condensationoxygen of the intermediate. A developing negative charge
on the carbonyl oxygen upon a nucleophilic attack of the of a carboxylic acid and an amine consumes free energy,
the formation of a peptide bond requires chemical acti-cysteine’s amino group on the carbonyl carbon could
be stabilized by the contact to water W2. Other groups vation of its components and is linked to nucleoside-
triphosphate hydrolysis. Both enzymes use a mecha-like the backbone amide of Val277 (at 3.8 A˚ distance)
do not form direct contacts to stabilize the developing nism that is also responsible for the activation of amino
acids used for ribosomal (reviewed in Ibba and Soll,oxyanion. The negative charge of Asp210 may decrease
the nucleophilicity of the amino group by the formation 2000) and nonribosomal biosynthesis (reviewed in Cane
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et al., 1998; Schwarzer et al., 2002) of peptides: in the dimerization domain residue, Lys289 of this motif con-
tacts the CTP or acyl-intermediate phosphates in thefirst step, all these enzymes form activated (amino)acyl-
AMP intermediates (with the exception of bacterial PPC neighboring subunit. The nucleobase binding site is
completed by the less well-conserved nucleotide bind-synthetases, which form acyl-cytidylate intermediates).
The crystallographic snapshots now provided in this ing motif II that discriminates between ATP and CTP as
it provides specific hydrogen bonds between proteinstudy allow a detailed description of the PPC synthetase
reaction and a comparison with the pantothenate syn- backbone atoms and the nucleobase moiety. In ecCoab
it includes Asn307-Pro-Asp-Ile-Val. Surprisingly, Asp309thetase reaction. In the first step, CTP binds to the en-
zyme mediated by a divalent metal ion (Figure 4A). It (located on the face of the base opposite to Val277) is
strictly conserved, although the side chain is not in-is at present unclear whether 4-phopshopantothenate
can bind independently of CTP. 4-Phopshopantothen- volved in specific contacts other than a network of posi-
tively and negatively charged residues. The nucleobaseate will be positioned ideally for an in-line attack of its
carboxylate group on the -phosphate of CTP, releasing binding motif II in eukaryotic (ATP binding) CoaBs devi-
ates from the bacterial. In the human enzyme, the se-diphosphate. The intermediate 4-phosphopantothen-
oyl-CMP is tightly bound to the enzyme in a well ordered quence reads: Val210-Pro-Lys-Leu-Leu. Pro211-Lys are
strictly conserved and represent a clear distinction be-manner (Figure 4B). Binding of cysteine to ecCoaB will
occur only after the formation of the intermediate as tween CTP- and ATP-dependent CoaBs. Sequence
comparison suggests that archaeal PPC synthetasesthe latter contributes, together with Phe362 from the
otherwise flexible substrate binding flap, a substantial are ATP-dependent enzymes.
Two other motifs participate primarily in binding ofportion to the small active site cavity next to the scissile
acyl-phosphate bond. This model is corroborated by the 4-phosphopantothenoyl- and the acyl-phosphate-
moiety. The phosphopantothenate binding motif Ithe fact that no density for cysteine is observed in the
product complex after soaking intermediate-complex Asn210-His-Ser-Ser-Gly-Lys contributes Asn210, a resi-
due that is presumably involved in cysteine binding, atcrystals with high concentrations of cysteine (Figure 4C).
The latter complex demonstrates also that the product the scissile acyl-phosphate bond. The side chains of
His211 and Val355 anchor the substrate binding flap by4-phophopantothenoyl-cysteine has significantly lower
affinity for the enzyme. Only density for its 4-phosphate- a contact to the side chain of Phe362. Ser212 to Lys215
bind the phosphate of the 4-phosphopantothenoyl-moi-group is visible.
A similar sequence of events has been observed in ety. The phosphopantothenate binding motif II Gly326-
Phe-Ala-Ala binds the -alanine part (Gly326-Phe) ofpantothenate synthetase by solution studies (Zheng and
Blanchard, 2001) and illustrated by structural studies in panthothenate and contributes to the binding site of the
acyl-phosphate-moiety (Ala328-Ala).molecular details (Wang and Eisenberg, 2003). Panto-
thenate synthetase catalyzes the ATP-dependent con- Interestingly, the substrate binding flap (“H6”) is not
well conserved in length or sequence presumably be-densation of pantoate and -alanine in two steps as a
“Bi Uni Uni Bi Ping Pong” mechanism. In the first step, cause interactions with the 4-phosphopantothenoyl-
moiety mainly involve backbone atoms.ATP binds to the enzyme followed by pantoate binding
and release of pyrophosphate. In the second step
-alanine binds to the pantoyl adenylate to form panto-
Comparison to Human PPC Synthetasethenate and AMP. The crystal structure of pantothenate
With the PPC synthetase structure from E. coli, analyzedsynthetase in complex with the reaction intermediate
in this study, and the recently determined human en-pantoyl adenylate provides insight into how the peptide
zyme (Manoj et al., 2003), representatives of both thebond in pantothenate is formed. In this dimeric enzyme,
classes of CoaB proteins are known. Comparison ofsubstrate binding is mediated by a partially flexible wall
both prototypes shows that major structural featuresof the active site cavity and brings the carbonyl oxygen
are conserved between both classes. Most notably,of pantoate near the -phosphorus atom of ATP for an
both form essentially identical dimers (Figure 6A). Thein-line nucleophilic attack. Similar to ecCoaB, the acyl-
latter was not clear a priori taking the different oligomericintermediate is quite stable when bound to the enzyme.
states of Dfp and human CoaB into account. Dimeriza-Binding of -alanine can only occur after pantoyl adenyl-
tion in both enzymes is largely mediated by a dimeriza-ate is formed inside the active site. We conclude that
tion domain jointly formed by both monomers. It is com-the formation of both peptide bonds in coenzyme A bear
prised of a four-stranded antiparallel  sheet formedsignificant mechanistic similarities.
from the insertion into the -module 1 (human: Lys46
to Asp58, E. coli: Thr198 to Asn210) and an antiparallel
two-stranded  sheet on top of the four-stranded Conserved Sequence Motifs
Sequence comparison of bacterial CoaB proteins show sheet formed from parts of the insertion into -module
4 (human: Asp183 to Val210; E. coli: Ala278 to Lys306). Infour sequence motifs that are involved in substrate bind-
ing. Two are primarily involved in CTP binding. The nu- both structures, the latter reaches out to the neighboring
subunit and is positioned partially as a disordered loopcleotide binding motif I is comprised of Ala275-Ala-Val-
Ala-Asp-X9-Lys289-X-Lys-Lys. Ala275-Ala are close to near the entry to the active site (last ordered residues:
human: Met191 to Leu203; E. coli: Ile290 to Glu299). Wethe acyl-phosphate bond and the ribose, the side chain
of Val277 supports one face of the nucleobase, and propose that this region may control access of cysteine
to the acyl-cytidylate intermediate.Asp279 binds the divalent metal ion bound to CTP. Sep-
arated by nine (or eight) residues that run across the The monofunctional eukaryotic CoaB enzymes con-
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Figure 6. Comparison of Bacterial and Human CoaB
(A) Superposition of human (gold) and E. coli CoaB (blue). Human CoaB is a monofunctional dimer in solution and has an additional dimerization
domain.
(B) Comparison of nucleotide binding sites. The C-trace for ecCoaB is shown in blue, for the human enzyme in gold. The bound
4-phosphophopantothenoyl-CMP in ecCoaB is shown as a ball-and-stick model. The larger binding pocket in the human enzyme is required
to accommodate an adenosyl-moiety instead of a cytidyl-moiety.
tain an additional dimer interface not present in the bac- bound to the E. coli structure. Ealick and coworkers
have modeled substrate binding in human CoaB by plac-terial CoaB proteins. This most significant difference
represents an insertion between Ala93 and Gly142 in ing the ATP phosphates at this site (Manoj et al., 2003).
This, however, is in clear contradiction to the substrate-module 2 of human PPC synthetase. It is comprised
of two -helical segments and a  hairpin. In the dimer, binding mode found in ecCoaB. Modeling the acyl-inter-
mediate in human PPC synthetase as observed in thethese modules resemble two hands grasping one an-
other and form extensive contacts that certainly largely E. coli enzyme predicts reasonable interactions through-
out, often with conserved residues like Phe327 (E. coli)/increase dimer stability. These contacts are dispensable
in Dfp where the N termini of each monomer are cova- Phe230 (human). Finally, conservation of Asp279
(E. coli)/Asp183 (human), which binds the divalent metallently anchored to the PPC decarboxylase core. Another
difference is an  helix in the human enzyme that pre- in the ecCoaB CTP complex at the nucleotide binding
site strongly suggests that both enzymes bind the sub-cedes 1 and packs against 2 and 3. The central
eight-stranded  sheets of both enzymes superimpose strates in similar manner and share basically the same
enzymatic mechanism.excellently, which is also true for the phosphate binding
site formed by Phe60-Ser-Ser-Gly-Arg-Arg-Gly in hu- The different nucleotide dependencies—ATP in the
human, CTP in the E. coli enzyme—can now be rational-man PPC synthetase and His211-Ser-Ser-Gly-Lys-Met-
Gly in the E. coli enzyme. ized on a structural basis: both enzymes deviate signifi-
cantly in the base-interacting parts of their nucleotideThere is strong evidence that both enzymes share the
mode of substrate binding and the enzymatic mecha- binding sites (Figure 6B). Although some conformational
changes and especially ordering of binding loops arenism. It has been pointed out that PPC synthetases
share this phosphate binding site with members of the observed upon substrate binding in the E. coli enzyme,
the nucleotide binding pocket in ecCoaB is quite rigid.ribokinase family (Manoj et al., 2003.). A sulfate ion
bound to this site in human PPC synthetase is placed Whereas the hydrophobic residue on  strand IVa that
supports one face of the nucleotidyl-moiety (Val277 inonly 1 A˚ away from the phosphate moiety of the 4-
phosphopantothenoyl part of the acyl-intermediate ecCoab, Val181 in human Coab) and the position of the
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with two column volumes of column buffer, the protein was elutedmetal binding aspartic acid (Asp279 in ecCoab, Asp183
using a linear gradient from 10 to 250 mM imidazole in washingin human Coab) on  strand IVa is conserved, the posi-
buffer. The protein was dialyzed against 20 mM Tris-HCl (pH 8.0)tion of  helix 5 and the preceding connection to 
and applied to a Q-Sepharose column equilibrated with 20 mM Tris-
strand IVb (Lys306 to Ala312 in ecCoaB, Met209 to HCl (pH 8.0), 10 mM NaCl. CoaB was eluted with a linear gradient
Pro216 in human CoaB) differs significantly. This region to 400 mM NaCl and concentrated to 10 mg/ml by ultrafiltration.
The buffer was finally exchanged to 20 mM Tris-HCl (pH 8.0) andprovides hydrogen bonds and shows strong shape com-
10 mM NaCl, and the protein was flash-frozen in liquid nitrogen andplementarity to the nucleobase adenin and cytosin, re-
stored at 
20	C. Protein concentrations were determined by thespectively. In the human enzyme (Manoj et al., 2003), this
Bradford method (Bradford, 1976) with bovine serum albumin asregion is shifted outwards which enlarges the nucleotide
standard. For the production of SeMet-incorporated protein, cells
binding pocket. Modeling of an adenosyl-moiety in the were grown as above in new minimal medium (Budisa et al., 1995),
proposed binding pocket predicts favorable interactions but with lower concentrations of phosphate buffer (22 mM KH2PO4
and 50 mM K2HPO4).without significant clashes. However, it should be noted
that the region around Ser215 in the human enzyme has
Crystallizationsignificantly higher temperature factors of about 70 A˚2
Enzymatically active CoaB was crystallized using the sitting dropcompared to the average of the protein of about 43 A˚2,
vapor diffusion method with each drop containing 2 l of 12 mg/mlwhich probably indicates some flexibility.
protein and 2 l of reservoir solution. The optimized reservoir solu-
The 4-phosphopantothenoyl-moiety is largely cov- tion contained 15% polyethyleneglycol 3350 and 0.1 M ammonium
ered by a rather bulky loop connecting  strands 6 and nitrate. Crystals of space group C2 appeared after several days and
grew to their maximum size of approximately 200  60  60 m36b (Asp354 to Asn367) that is reminiscent of a partially
in about two weeks. The SeMet-incorporated protein crystallizedunwound  helix. In the human enzyme, this loop is
under identical conditions but yielded smaller crystals (150  40 shorter (Ile259 to Ser265) by seven residues but com-
40 m3).pletely disordered in the absence of substrate like its
For cocrystallization with CTP, the protein with a concentration
E. coli counterpart. The shorter loop could cover the of 15 mg/ml was mixed with 2 mM CTP and 1 mM DTT. Crystals of
substrate in a more extended fashion as observed for space group C222(1) were obtained in drops of 4 l with protein to
mother liquor at a 3:1 (v/v) ratio with 0.1 M calcium acetate, 0.1 Mthe flexible substrate binding clamps in EpiD (Blaesse
Tris-HCl (pH 6.6), and 16% polyethyleneglycol 3000 after 10 days.et al., 2000) or AtHAL3 (Steinbacher et al., 2003). We
4-Phosphopantothenate was synthesized enzymatically as de-propose that human and E. coli PPC synthetase share
scribed earlier (Kupke, 2002, 2004). A 100 mM solution of calciumthe binding mode of substrates and the enzymatic
pantothenate (Fluka) was mixed with tri-sodium phosphate and the
mechanism of the metal activated reaction of ATP or precipitating Ca-phosphate removed by centrifugation. Five milli-
CTP with 4-phosphopantothenate. molar of the formed sodium pantothenate was enzymatically con-
verted by recombinant His-tagged pantothenate kinase CoaA (15
g) with 5 mM ATP and 2.5 mM MgCl2 in 50 mM Tris-HCl (pHConclusions
8.0). After 45 min of incubation at 37	C, His-CoaA was removed by
centrifugation through an Ni-NTA spin column (Qiagen). The 4-
In summary, the present study provides detailed struc- phosphopantothenate in the flow through was concentrated to 20
tural information on yet another realization of a central mM by reducing the volume in the vacuum. The CoaB protein with
a concentration of 15 mg/ml was mixed with 2 mM 4-phosphopan-biochemical reaction: the enzyme-catalyzed formation
tothenate, 2 mM CTP, and 1 mM DTT. Crystals of space groupof a peptide bond. A recurrent principle is activation of
C222(1) were obtained in drops of 4 l with protein to mother liquorthe carboxylic acid by formation of a high-energy acyl-
at a 2:2 (v/v) ratio with 0.2 M lithium acetate and 20% polyethyl-phosphate moiety and its lysis by a nucleophile. This
eneglycol 3350 after 5 days.
can either be directly the amino-group of cysteine as in
the CoaB-catalyzed reaction to directly form a peptide Data Collection, Data Processing, and Phasing
bond or the hydroxyl or thiol group of another carrier For data collection, crystals were transferred into perfluropolyether
(PFO, Lancaster) as cryo protectant and adhering mother liquor wasmolecule when a higher complexity of products has to
completely removed with thin glass capillaries. All crystals werebe achieved.
directly frozen in a nitrogen stream of 100K (Oxford Cryosystems).The presented structural data will be a valuable tool
Data were collected at 100K at DESY, Hamburg (beam line BW6)for the design of bacterial PPC synthetase inhibitors
on a MAR CCD detector. Processing and scaling of the diffraction
which then might be further developed to new antibi- data sets were performed with the HKL (Otwinowski and Minor,
otics. 1997) and the CCP4 (CCP4, 1994) program suites.
The ligand-free structure was solved by MAD with data collected
at three wavelengths from a seleno-methionine substituted deriva-Experimental Procedures
tive crystal. Five selenium positions were located using SHELXS
(Sheldrick et al., 1993) using anomalous data of the peak wavelengthProtein Expression and Purification
A CoaB-harboring fragment of the Dfp protein which spans residues and refined with MLPHARE (CCP4, 1994). Phasing statistics indi-
cated a strong anomalous signal to about 3.5 A˚. Phases were calcu-Ser181 to the C-terminal Arg406 was produced as described using
expression vector pQE8 with an N-terminal hexa-His tag which adds lated between 20 and 2.7 A˚ resolution. The mean figure of merit
was 0.34 between 20 and 2.7 A˚. The phasing powers were 0.20 forthe sequence Met-Arg-Gly-Ser-His6-Gly. (Kupke, 2002). Briefly,
E. coli M15 (pREP 4) transformed with the expression construct the remote (  1.05 A˚) and 0.24 for the inflection (  0.9793 A˚)
wavelength, respectively. The anomalous Rcullis was 0.78 for the peak,were grown at 37	C in 1 l LB cultures in 2 l shaker flasks to an OD600
of 0.6. After induction with 1 mM IPTG, they were incubated at 18	C 0.91 for remote, and 0.93 for inflection wavelength, respectively.
Data collected at the peak wavelength (  0.9797 A˚) were used asfor 24 hr before cells were harvested by centrifugation at 4	C. Cells
from 2 l of culture were suspended in 10 ml of 20 mM Tris-HCl (pH reference. The electron density was improved by solvent flattening
using RESOLVE (Terwilliger and Berendzen, 1999). The complex8.0) and 20 mM NaCl and disrupted by sonification. The soluble
fraction obtained after centrifugation was applied to a Ni-NTA col- structures were solved by molecular replacement using the program
MOLREP (CCP4, 1994) with the substrate-free structure of E. coliumn (Qiagen) equilibrated with column buffer (20 mM Tris-HCl [pH
8.0], 10 mM imidazole, and 300 mM NaCl). After washing the column CoaB used as Patterson search model for the CTP-complex.
Structure of Bacterial CoaB
1987
Model Building and Refinement characterization of phosphopantetheine adenylyltransferase from
Escherichia coli. J. Biol. Chem. 274, 27105–27111.Model building was performed with the program MAIN (Turk, 1992).
The initial model of the ligand-free form was built in the 2.7 A˚ resolu- Gerdes, S.Y., Scholle, M.D., D’Souza, M., Bernal, A., Baev, M.V.,
tion MAD electron density map and refined against the 2.4 A˚ resolution Farrell, M., Kurnasov, O.V., Daugherty, M.D., Mseeh, F., Polanuyer,
native data set. The structures were refined with CNS (Bru¨nger et B.M., et al. (2002). From genetic footprinting to antimicrobial drug
al., 1998) with noncrystallographic symmetry restraints. Restraints targets: examples in cofactor biosynthetic pathways. J. Bacteriol.
were varied to minimize Rfree. Stronger restraints were applied for the 184, 4555–4572.
low-resolution data set CMP. The resulting rms deviations between
Herna´ndez-Acosta, P., Schmid, D.G., Jung, G., Culia´n˜ez-Macia`, F.A.,
monomers were between 0.25 A˚ for model CMP and 0.53 A˚ for the
and Kupke, T. (2002). Molecular characterization of the Arabidopsis
model PCMP. Anisotropic B-factor and bulk solvent corrections
thaliana flavoprotein AtHAL3a reveals the general reaction mecha-
were applied.
nism of 4-phosphopantothenoylcysteine decarboxylases. J. Biol.
Chem. 277, 20490–20498.
Analysis and Graphical Representation Ibba, M., and Soll, D. (2000). Aminoacyl-tRNA synthesis. Annu. Rev.
Structural figures were prepared with MOLSCRIPT (Kraulis, 1991), Biochem. 69, 617–650.
BOBSCRIPT (Esnouf, 1997), and GRASP (Nicholls et al., 1993) and
Jackowski, S., and Rock, C.O. (1984). Metabolism of 4-phospho-were rendered with Raster3D (Merritt and Bacon, 1997). Figure 3
pantetheine in Escherichia coli. J. Bacteriol. 158, 115–120.was prepared with ALSCRIPT (Barton, 1993).
Kleinkauf, H. (2000). The role of 4-phosphopantetheine in the bio-
synthesis of fatty acids, polyketides and peptides. Biofactors 11,Acknowledgments
91–92.
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